SCHEMBL21707448

SCHEMBL21707448

CC1(CN)C2CC[C@H]3CC2C1C3

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23369721 1.00
SCHEMBL23369736 1.00
SCHEMBL21621835 0.69 EPHX2 (0.38)
SCHEMBL23369741 0.69 EPHX2 (0.38)
Crisugabalin SCHEMBL21621701 0.65 POLB (0.35)
Crisugabalin SCHEMBL21144567 0.65 POLB (0.35)
Crisugabalin SCHEMBL24631233 0.65 POLB (0.35)
Crisugabalin SCHEMBL23080592 0.65 POLB (0.35)
Crisugabalin SCHEMBL23080519 0.65 POLB (0.35)
Crisugabalin SCHEMBL21144566 0.65 POLB (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020029762-A1 PREPARATION METHOD FOR FUSED TRICYCLIC γ-AMINO ACID DERIVATIVE AND INTERMEDIATE THEREOF 四川海思科制药有限公司 2020-02-13 WO disclosed